AG Brown leads coalition petitioning the FDA to remove burdensome restrictions on mifepristone
Published Date: Aug 20, 2025
- Categories
- Action Type Letter
Attorney General Nick Brown and 16 other states, as well as the District of Columbia, are requesting the U.S. Food and Drug Administration (FDA) remove burdensome restrictions on mifepristone, one of two drugs used in medication abortions, the most common means of abortion in the U.S.
The coalition today submitted a filing presenting extensive evidence on the safety of medication abortion in their states as well as the burdens imposed by the FDA’s continued restrictions on mifepristone. In today’s filing, the states join and supplement a citizen petition filed with the FDA by Massachusetts, California, New Jersey, and New York on June 5. The coalition urges the agency to eliminate unnecessary restrictions on this safe medication that make it much harder for patients to access medication abortions, particularly in rural and medically underserved areas.
“Mifepristone has been safely used by millions of women in this country over the last 25 years. In a post-Dobbs world, we should be removing unnecessary barriers to reproductive health care in states that protect abortion so people have the freedom to plan when and whether to have a family.” – AG Brown